Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationThe Health Research Authority has published guidance explaining the changes introduced by the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025, which will take effect on 28 April 2026.
The Health Research Authority (HRA) has launched a pilot to gather feedback on a new Information Governance (IG) guide for research.
The MHRA has updated the Good Clinical Practice for clinical trials guidance to include new Corrective Action and Preventive Action (CAPA) support for inspection responses.
The MHRA has published its new approach to bolstering cyber security across its supply chains to better protect regulated products and services.
The European Medicines Agency’s Human Medicines Highlights newsletter provides key regulatory updates for medicines in the EU.
The MHRA shares insights on how regulatory frameworks can drive innovation and economic growth across UK regions.
The MHRA and NICE now offer a joined-up scientific advice service to help medicine developers align regulatory and health technology assessment evidence needs early in development.
UK medical device testing hits record high as MHRA backs growth in brain and AI technology
Consultation open: 11/02/2026 to 11/04/2026
Consultation dates: 09/02/2026 to 09/04/2026